Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Heimpel Butts, Jodi Lynn. Officer active across 2 companies, notably Canada Goose Holdings Inc.. In total, 16 disclosures have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €19k. History available since 28 May 2026. The latest transaction was disclosed on 15 June 2026 (51 - Exercise of options). Regulator: SEDI. The full history is accessible without signup.
Companies and markets linked to Heimpel Butts, Jodi Lynn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23,169 shares@ CA$13.810.024% mcap61.7% of flowOptionsTSXSEDI:4727465
16 of 16 declarations
About Heimpel Butts, Jodi Lynn
Heimpel Butts, Jodi Lynn is a declarant linked to Canada Goose Holdings Inc. and Pharmala Biotech Holdings Inc., where the listed role is 4 - Director of Issuer. The record shows 16 filings in total, and among the sampled recent filings from 2026-06-02 to 2026-06-17, total purchases are EUR 19072, with no reported sales, and the modal transaction nature is 57 - Exercise of rights.